FrancophonIA/ELRC3.0 huggingface dataset:
English: External heat, for example from hot water bottles or heat pads, should be avoided on the area of the transdermal patch.
Slovenian: V predelu obliža se izogibajte zunanji toploti, na primer iz termoforja ali ogrevalne blazine.
English: You may see mild redness on the skin where the transdermal patch is removed.
Slovenian: Na koži, kjer ste odstranili transdermalni obliž, boste mogoče videli blago rdečino, ki bo sčasoma izginila.
English: Nervous system disorders
Slovenian: Bolezni živčevja glavobol distonija občasni redki redki diskinezija
English: The transdermal patch can be worn for up to 7 days depending on the duration of your chemotherapy treatment.
Slovenian: Odvisno od trajanja kemoterapije lahko transdermalni obliž nosite do 7 dni.
English: General disorders and administration site conditions
Slovenian: Splošne težave in spremembe na mestu aplikacije generaliziran edem občasni
English: Ear and labyrinth disorders
Slovenian: Ušesne bolezni, vključno z motnjami labirinta vrtoglavica občasni
English: Hypersensitivity reactions
Slovenian: - alergijske kožne reakcije.
English: Flushing
Slovenian: OVOJNINAH
English: Date of first authorisation: 10 September 2013 Date of latest renewal: 21 June 2018
Slovenian: Datum prve odobritve: 10. september 2013 Datum zadnjega podaljšanja: 21. junij 2018
English: • reduce the signs and symptoms of your disease,
Slovenian: • zmanjšanje znakov in simptomov vaše bolezni,
English: Children and adolescents The information above also applies to children and adolescents.
Slovenian: Otroci in mladostniki Zgoraj navedene informacije veljajo tudi za otroke in mladostnike.
English: Adults (≥18 years)
Slovenian: Odrasli bolniki (≥ 18 let)
English: Some of these reactions may be serious or life-threatening.
Slovenian: Nekateri od teh učinkov so lahko resni ali življenjsko ogrožujoči.
English: If you are 65 years of age or older, you have a greater risk.
Slovenian: Če ste stari 65 let ali več, je to tveganje večje.
English: • Orencia (which contains abatacept).
Slovenian: • Orencia (ki vsebuje abatacept).
English: The reconstituted solution should stand for 5 minutes.
Slovenian: Rekonstituirana raztopina mora stati 5 minut.
English: • Kineret (which contains anakinra).
Slovenian: • Kineret (ki vsebuje anakinro).
English: • improve your physical function.
Slovenian: • izboljšanje telesne sposobnosti.
English: In particular, tell your doctor if you are using any of the following medicines:
Slovenian: Še posebej povejte svojemu zdravniku, če uporabljate katero od naslednjih zdravil:
English: (furunculosis)
Slovenian: (plevritis)
English: • Blood test result showing ‘antibodies' against your own body.
Slovenian: • rezultati krvnih preiskav, ki zaznajo ''protitelesa'' proti vašemu lastnemu telesu
English: 23 Academy-ro, Yeonsu-gu, Incheon, 22014 Republic of Korea
Slovenian: 23 Academy -ro, Yeonsu-gu, Incheon, 22014 Republika Koreja
English: Before reconstitution
Slovenian: Pred rekonstitucijo
English: • The table below shows how often you will usually have this medicine after your first dose.
Slovenian: • Spodnja preglednica prikazuje, kako pogosto boste prejemali to zdravilo po prvem odmerku.
English: These infections are caused by specific types of fungi that can affect the lungs or other parts of your body.
Slovenian: Te okužbe povzročajo posebne vrste glivic, ki lahko prizadenejo pljuča ali druge dele telesa.
English: • Severe allergic reaction that may cause loss of consciousness and could be life-threatening
Slovenian: • huda alergijska reakcija, ki lahko povzroči izgubo zavesti in je lahko smrtno nevarna
English: • you are allergic to infliximab or any of the other ingredients of this medicine (listed in section 6),
Slovenian: • če ste alergični na infliksimab ali katerokoli sestavino tega zdravila (navedeno v poglavju 6),
English: It is important that you and your doctor record the brand name and batch number of your medicine.
Slovenian: Pomembno je, da vi in zdravnik zabeležita lastniško ime in številko serije vašega zdravila.
English: The solution should be colourless to light yellow and opalescent.
Slovenian: Raztopina mora biti brezbarvna do svetlo rumena in opalescentna.
English: placebo inflixim ab placebo inflixim ab placebo inflixim ab placebo inflixim ab
Slovenian: placebo infliksimab placebo infliksimab placebo infliksimab placebo infliksimab
English: This evaluation should include colonoscopy and biopsies per local recommendations.
Slovenian: Med te teste sodijo na primer kolonoskopija in biopsije v skladu z lokalnimi priporočili.
English: EU/1/13/854/001 1 vial EU/1/13/854/002 2 vials EU/1/13/854/003 3 vials EU/1/13/854/004 4 vials EU/1/13/854/005 5 vials
Slovenian: EU/1/13/854/001 1 viala EU/1/13/854/002 2 viali EU/1/13/854/003 3 viale EU/1/13/854/004 4 viale EU/1/13/854/005 5 vial
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation holder:
Slovenian: Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:
English: • Abnormal values of a blood protein called ‘complement factor' which is part of the immune system.
Slovenian: • nenormalne vrednosti beljakovine v krvi, imenovane ''faktor komplementa'', ki je del imunskega sistema
English: Table 9 Effects on ACR and PASI in IMPACT and IMPACT 2 IMPACT
Slovenian: Preglednica 9 Učinki na ACR in PASI v študijah IMPACT in IMPACT 2
English: • In some patients receiving infliximab, the body may not make enough of the blood cells that help fight infections or help stop bleeding.
Slovenian: • Pri nekaterih bolnikih, ki prejemajo infliksimab, telo morda ne tvori dovolj krvnih celic, ki se borijo proti okužbam ali pripomorejo k zaustavitvi krvavitve.
English: Pack sizes of 1, 2, 3, 4, 5 vials.
Slovenian: Velikosti pakiranja 1, 2, 3, 4, 5 vial.
English: In this trial, sixty-six percent of the patients (686 out of 1,040) received at least one shortened infusion of 90 minutes or less and 44% of the patients (454 out of 1,040) received at least one shortened infusion of 60 minutes or less.
Slovenian: V tem preskušanju je 66 % bolnikov (686 od 1.040) prejelo najmanj eno skrajšano infuzijo v trajanju 90 minut ali manj, 44 % bolnikov (454 od 1.040) pa je prejelo najmanj eno skrajšano infuzijo v trajanju 60 minut ali manj.
English: • Your doctor should test you for hepatitis B virus.
Slovenian: • Vaš zdravnik vas mora testirati za virus hepatitisa B.
English: This will depend on your disease, weight and how well you respond to Inflectra.
Slovenian: To bo odvisno od vaše bolezni, telesne mase in tega, kako se odzivate na zdravilo Inflectra.
English: Shortened infusions at doses >6 mg/kg have not been studied (see section 4.8).
Slovenian: Uporabe skrajšanih infuzij v odmerkih > 6 mg/kg niso proučevali (glejte poglavje 4.8).
English: THE VIAL MUST NOT BE SHAKEN.
Slovenian: VIALE NE SMETE STRESATI!
English: No dose adjustment is required (see section 5.2).
Slovenian: Prilagoditev odmerka ni potrebna (glejte poglavje 5.2).
English: • you have tuberculosis (TB) or another serious infection such as pneumonia or sepsis(serious bacterial infection of the blood),
Slovenian: • če imate tuberkulozo (TBC) ali katero drugo hudo okužbo, npr. pljučnico ali sepso (resno bakterijsko okužbo krvi),
English: 5 years at 2 °C - 8 °C.
Slovenian: 5 let pri temperaturi 2 °C - 8 °C.
English: If visibly opaque particles, discolouration or foreign particles are observed it should not be used.
Slovenian: Če opazite vidne neprosojne delce, obarvanje ali tuje delce, ga ne smete uporabiti.
English: Prior therapy with PUVA, methotrexate, ciclosporin, or acitretin had been received by 71.4% of patients, although they were not necessarily therapy resistant.
Slovenian: Predhodno terapijo s PUVA, metotreksatom, ciklosporinom ali acitretinom je prejelo 71,4 % bolnikov, čeprav ni nujno, da so bili odporni na uvodno terapijo.
English: Keep this card with you for 4 months after your last dose of Inflectra, or in case of pregnancy, for at least 6 months after the birth of your baby.
Slovenian: To kartico imejte pri sebi še 4 mesece po zadnjem odmerku zdravila Inflectra ali v primeru nosečnosti še vsaj 6 mesecev po rojstvu otroka.
English: N ≥ 90% improvement ≥ 75% improvement ≥ 50% improvement
Slovenian: ≥ 90 % izboljšanje ≥ 75 % izboljšanje ≥ 50 % izboljšanje
English: EXP EXP, if not refrigerated _________________________
Slovenian: EXP Rok uporabnosti izven hladilnika ___________________
English: Hypersensitivity to the active substance, to other murine proteins, or to any of the excipients listed in section 6.1.
Slovenian: Preobčutljivost na učinkovino, druge glodalske beljakovine ali katerokoli pomožno snov, navedeno v poglavju 6.1.
English: • If you experience reactivation of hepatitis B, your doctor may need to stop your treatment and may give you medicines such as effective antiviral therapy with supportive treatment.
Slovenian: • Če pri vas pride do reaktivacije hepatitisa B, bo zdravnik morda moral prekiniti vaše zdravljenje in vam dati zdravila za učinkovito protivirusno zdravljenje skupaj s podpornim zdravljenjem.
English: Complete fistula response (%)
Slovenian: Odziv fistule (%)
English: If you feel tired, dizzy, or unwell after having Inflectra, do not drive or use any tools or machines.
Slovenian: Če se po prejemu zdravila Inflectra počutite utrujeni, omotični ali se ne počutite dobro, ne smete voziti ali upravljati s kakršnimikoli orodji ali stroji.
English: All patients administered infliximab are to be observed for at least 1-2 hours post-infusion for acute infusion-related reactions.
Slovenian: Vse bolnike, ki prejmejo infliksimab, je treba opazovati najmanj 1 do 2 uri po infuziji zaradi akutnih z infuzijo povezanih reakcij.
English: • Contact details of the prescriber
Slovenian: • kontaktne podatke predpisovalca.
English: Inflectra is also used in adults and children 6 years of age or older for:
Slovenian: Zdravilo Inflectra se uporablja tudi za zdravljenje odraslih in otrok starih 6 let in več za:
English: This evaluation should include a detailed medical history with personal history of tuberculosis or possible previous contact with tuberculosis and previous and/or current immunosuppressive therapy.
Slovenian: Pregled mora vključiti podrobno zdravstveno anamnezo in osebno anamnezo v zvezi s tuberkulozo ali morebitnimi prejšnjimi stiki s tuberkuloznimi bolniki in v zvezi z morebitno prejšnjo in/ali sedanjo imunosupresivno terapijo.
English: • If you have had a break in your treatment with infliximab of more than 16 weeks, there is a higher risk for allergic reactions when you start the treatment again.
Slovenian: • Če ste prekinili zdravljenje z zdravilom, ki vsebuje infliksimab, za več kot 16 tednov, obstaja večje tveganje za pojav alergijskih reakcij ob ponovni uvedbi zdravljenja.
English: • It is recommended that when Inflectra is prepared for infusion, it is used as soon as possible (within 3 hours).
Slovenian: • Priporočljivo je, da se pripravljeno raztopino za infuzijo zdravila Inflectra uporabi čimprej (v 3 urah).
English: Patients who have had their dose interval shortened to less than 8 weeks may be at greater risk for adverse reactions.
Slovenian: Pri bolnikih, pri katerih je bil razmik med odmerki skrajšan na manj kot 8 tednov, lahko obstaja večje tveganje za pojav neželenih učinkov.
English: Inflectra should only be used during pregnancy if your doctor feels it is necessary for you.
Slovenian: Zdravilo Inflectra se lahko uporablja med nosečnostjo le, če zdravnik meni, da je to pri vas potrebno.
English: Inflectra, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:
Slovenian: Zdravilo Inflectra je v kombinaciji z metotreksatom indicirano za zmanjšanje znakov in simptomov ter izboljšanje funkcije sklepov:
English: Patients who did not respond to infliximab at week 8 (n=15) received no further medicinal product and returned for safety follow-up.
Slovenian: Bolniki, ki se do 8. tedna niso odzvali na infliksimab (n = 15), niso več prejemali zdravila in so se vrnili na kontrolni pregled glede varnosti.
English: Re-administration for Crohn's disease and rheumatoid arthritis If the signs and symptoms of disease recur, infliximab can be re-administered within 16 weeks following the last infusion.
Slovenian: Ponovna uporaba zdravila pri Crohnovi bolezni in revmatoidnem artritisu Če se znaki in simptomi bolezni ponovijo, lahko infliksimab ponovno uporabite v roku 16 tednov po zadnji infuziji.
English: In children (6 years of age or older) treated for Crohn's disease or ulcerative colitis, the recommended dose is the same as for adults.
Slovenian: Pri otrocih (starih 6 let ali več), ki se zdravijo zaradi Chronove bolezni ali ulceroznega kolitisa, je priporočeni odmerek enak kot pri odraslih.
English: The potential risk with the combination of AZA or 6-MP and infliximab should be carefully considered.
Slovenian: Natančno je treba pretehtati potencialno tveganje pri sočasnem dajanju AZA ali 6-MP z infliksimabom.
English: 2 weeks after your 1
Slovenian: 2 tedna po prejetju prvega odmerka
English: For women taking Inflectra including those over 60 years of age, your doctor may recommend regular screening for cervical cancer.
Slovenian: Ženskam, ki prejemajo zdravilo Inflectra, vključno s starejšimi od 60 let, lahko zdravnik priporoči redne presejalne teste za raka materničnega vratu.
English: Because human immunoglobulins are excreted in milk, women must not breast feed for at least 6 months after infliximab treatment.
Slovenian: Ker pa se človeški imunoglobulini izločajo v materino mleko, matere ne smejo dojiti še najmanj 6 mesecev po zdravljenju z infliksimabom.
English: What you need to know before you use Inflectra
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Inflectra
English: Forty-six percent of patients continued on stable doses of methotrexate (≤ 25 mg/week).
Slovenian: 46 % bolnikov je zdravljenje nadaljevalo s stalnimi odmerki metotreksata (≤ 25 mg/teden).
English: Sustained Steroid-Free Remission b a Reduction in CDAI ≥ 25% and ≥ 70 points.
Slovenian: Ohranjena remisija brez jemanja steroidov a Zmanjšanje CDAI na ≥ 25 % oziroma ≥ 70 točk.
English: Some patients may require a shorter dosing interval to maintain clinical benefit, while for others a longer dosing interval may be sufficient.
Slovenian: Pri nekaterih bolnikih je za ohranjanje koristnih kliničnih učinkov zdravljenja lahko potreben krajši razmik med odmerki, pri drugih pa lahko zadoščajo infuzije v daljših časovnih razmikih.
English: Inflectra belongs to a group of medicines called ‘TNF blockers'.
Slovenian: Zdravilo Inflectra spada v skupino zdravil, ki se imenujejo "zaviralci TNF".
English: What Inflectra is and what it is used for
Slovenian: Kaj je zdravilo Inflectra in za kaj ga uporabljamo
English: Your doctor will test you to see if you have TB.
Slovenian: Zdravnik vas bo testiral, da bi ugotovil ali imate tuberkulozo.
English: These patients were classified as week-2 responders and were included in the primary analysis (see Table 5).
Slovenian: Ti bolniki so bili razvrščeni v skupino z odzivom v 2. tednu zdravljenja in so bili vključeni v primarno analizo (glejte Preglednico 5).
English: The storage details should you need them are as follows:
Slovenian: Pogoji shranjevanja pa so naslednji:
English: Inflectra is indicated for:
Slovenian: Zdravilo Inflectra je indicirano za:
English: • Tell your doctor if you have any heart problems, such as mild heart failure.
Slovenian: • Povejte svojemu zdravniku, če imate kakršnekoli težave s srcem, kot na primer blago srčno popuščanje.
English: • Patients with severe rheumatoid arthritis, who have had the disease for a long time, may be at higher risk of developing lymphoma.
Slovenian: • Bolniki z resnejšo obliko revmatoidnega artritisa, ki imajo to bolezen že dolgo časa, imajo lahko večje tveganje za nastanek limfoma.
English: It is important that you tell your baby's doctors and other healthcare professionals about your Inflectra use so they can decide when your baby should receive any vaccine, including live vaccines such as BCG (used to prevent tuberculosis).
Slovenian: Pomembno je, da zdravnike svojega otroka in druge zdravstvene delavce obvestite, da ste prejemali zdravilo Inflectra, da bodo lahko presodili, kdaj sme vaš dojenček prejeti katerokoli cepivo, vključno z živimi cepivi, kot je cepivo BCG (uporablja se za preprečevanje tuberkuloze).
English: If inactive (‘latent') tuberculosis is diagnosed, treatment for latent tuberculosis must be started with antituberculosis therapy before the initiation of infliximab, and in accordance with local recommendations.
Slovenian: V primeru diagnoze neaktivne (latentne) tuberkuloze morate uvesti zdravljenje za latentno tuberkulozo z antituberkulozno terapijo, še pred uvedbo infliksimaba, v skladu z lokalnimi priporočili.
English: Infliximab crosses the placenta and has been detected in the serum of infants up to 6 months following birth.
Slovenian: Infliksimab prehaja skozi posteljico in so ga vse do 6 mesecev po rojstvu zaznali v serumu dojenčkov.
English: In carefully selected adult patients who have tolerated at least 3 initial 2-hour infusions of infliximab (induction phase) and are receiving maintenance therapy, consideration may be given to administering subsequent infusions over a period of not less than 1 hour.
Slovenian: Pri skrbno izbranih odraslih bolnikih, ki so dobro prenesli vsaj 3 začetne 2-urne infuzije infliksimaba (uvajalna faza zdravljenja) in so trenutno na vzdrževalnem zdravljenju, lahko razmislite o skrajšanju naslednjih infuzij, vendar ne na manj kot 1 uro.
English: If you forget or miss an appointment to receive Inflectra, make another appointment as soon as possible.
Slovenian: Če ste pozabili ali izpustili dogovorjen termin, da bi prejeli zdravilo Inflectra, se čim prej dogovorite za naslednjega.
English: • The doctor will decide your dose and how often you will be given Inflectra.
Slovenian: • Zdravnik bo določil odmerek, ki ga boste prejemali, in kako pogosto ga boste prejemali.
English: Care should be taken and patients should continue to be monitored when switching from one biologic to another, since overlapping biological activity may further increase the risk for adverse reactions, including infection.
Slovenian: Pri prehodu z enega biološkega zdravila na drugega je potrebna previdnost, bolnike pa je treba še naprej spremljati, ker se zaradi prekrivanja biološke učinkovitosti lahko še poveča tveganje za neželene učinke, vključno z okužbami.
English: b all infliximab doses given in combination with methotrexate and folate with some on corticosteroids and/or
Slovenian: b Vsi odmerki infliksimaba so bili v kombinaciji z metotreksatom in folatom, nekaj tudi s kortikosteroidi in/ali
English: In all situations described below, the benefit/risk balance of infliximab therapy should be very carefully considered.
Slovenian: V vseh spodaj opisanih okoliščinah je treba zelo skrbno pretehtati razmerje med koristmi in tveganji zdravljenja z infliksimabom.
English: • These infections may be serious and include tuberculosis, infections caused by viruses, fungi, bacteria or other organisms in the environment and sepsis that may, be life-threatening.
Slovenian: • Te okužbe so lahko resne in lahko vključujejo tuberkulozo ter okužbe, ki jih povzročajo virusi, glivice, bakterije ali drugi organizmi v okolju, in sepso, kar je lahko smrtno nevarno.
English: Storage beyond 24 hours at 2 °C - 8 °C applies to preparation of Inflectra in the infusion bag only.
Slovenian: Shranjevanje pri temperaturi 2 °C - 8 °C, ki presega 24 ur, se nanaša samo na pripravo zdravila Inflectra v infuzijski vrečki.
English: Acute infusion reactions including anaphylactic reactions may develop during (within seconds) or within a few hours following infusion.
Slovenian: Akutna z infuzijo povezana reakcija, vključno z anafilaktično reakcijo, lahko nastopi med infuzijo (tj. v nekaj sekundah) ali v roku nekaj ur po infuziji.
English: Your doctor will advise you what other medicines you must keep using while you are having Inflectra.
Slovenian: Zdravnik vam bo svetoval, katera zdravila morate še naprej jemati tudi med zdravljenjem z zdravilom Inflectra.
English: N/A 60 N/A 49.4 N/A 6.7% N/A 1.7%
Slovenian: N/A 6,7 % N/A 1,7 %
English: The solution may develop a few fine translucent particles, as infliximab is a protein.
Slovenian: V raztopini se lahko pojavi nekaj majhnih prosojnih delcev, saj je infliksimab beljakovina.
English: For more information about the safety of infliximab in elderly patients (see sections 4.4 and 4.8).
Slovenian: Za več informacij o varnosti infliksimaba pri starejših (glejte poglavji 4.4 in 4.8).
English: Republic of Korea
Slovenian: Republika Koreja
English: • Provision to record the type, date, and result of TB screenings
Slovenian: • prostor za beleženje vrste, datuma in rezultata presejalnih testov za tuberkulozo (TBC);
English: Results from week 54 (ACR20, total van der Heijde-modified Sharp score and HAQ) are shown in Table 3.
Slovenian: Rezultati za 54. teden (za ACR 20, skupni rezultat po metodi van der Heijde, modificirani po Sharpu in HAQ) so prikazani v Preglednici 3.
English: At single doses of 3, 5, or 10 mg/kg, the median Cmax values were 77, 118 and 277 micrograms/mL, respectively.
Slovenian: Po enkratnem odmerku 3, 5 ali 10 mg/kg so bile mediane vrednosti Cmaks 77, 118 in 277 mikrogramov/ml.
English: Currently available data are described in sections 4.8 and 5.2 but no recommendation on a posology can be made.
Slovenian: Trenutno razpoložljivi podatki, so opisani v poglavjih 4.8 in 5.2, vendar ni mogoče podati priporočil za odmerjanje.
English: Cerebrovascular accidents in close temporal association with infusion.
Slovenian: cerebrovaskularni insulti v tesni časovni povezanosti z infuzijo
English: The card is aimed at both serving as a reminder to record the dates and outcomes of specific tests and to facilitate the patient sharing of special information with healthcare professionals (HCPs) treating the patient about on-going treatment with the product.
Slovenian: Kartica je namenjena tako beleženju datumov in rezultatov določenih preiskav kot tudi lažji izmenjavi posebnih informacij glede trenutnega zdravljenja z zdravilom med bolnikom in zdravstvenimi delavci, ki sodelujejo pri zdravljenju bolnika.
English: • A rare blood cancer affecting mostly teenage boys or young men (hepatosplenic T-cell lymphoma)
Slovenian: • redka vrsta krvnega raka, ki prizadane predvsem najstnike in mlade moške (hepatosplenični limfom T celic)
English: Only an infusion set with an in-line, sterile, non-pyrogenic, low protein-binding filter (pore size 1.2 micrometre or less) should be used.
Slovenian: Uporabite lahko le infuzijske komplete, opremljene z linijskim, sterilnim, nepirogenim filtrom, ki le malo veže beljakovine (velikost por 1,2 mikrometra ali manj).
English: Median Improvement from baseline in HAQ averaged over time from week 30 to week 54
Slovenian: Izboljšanje z začetne vrednosti za HAQ -časovno povprečje od 30. do 54. tedna
English: This includes multiple sclerosis, Guillain-Barré syndrome, if you have fits or have been diagnosed with ‘optic neuritis'.
Slovenian: To vključuje bolezni, kot so multipla skleroza, Guillain-Barréjev sindrom, če ste imeli napade krčev ali so vam diagnosticirali optični nevritis.
English: The safety and efficacy of re-administration after an infliximab-free interval of more than 16 weeks has not been established.
Slovenian: Varnost in učinkovitost ponovne uporabe po premoru brez infliksimaba, daljšem od 16 tednov, nista bili dokazani.
English: • A reminder to patients to show the patient reminder card to all treating HCPs, including in conditions of emergency, and a message for HCPs that the patient is using Inflectra
Slovenian: • opomnik za bolnike, da morajo opozorilno kartico za bolnika pokazati vsem zdravstvenim delavcem, ki sodelujejo pri zdravljenju (tudi v nujnih stanjih), vključno s sporočilom za zdravstvene delavce, da bolnik uporablja zdravilo Inflectra;
English: Infliximab should be administered intravenously over a 2 hour period.
Slovenian: Infliksimab je treba dajati intravensko v trajanju 2 uri.